Entrada Therapeutics Reports Third Quarter 2024 Financial Results
Go back to Entrada Therapeutics Reports Third Quarter 2024 Financial Results| (NASDAQ: TRDA) | Delayed: 7.54 -0.06 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.60 | 52 Week High | $ | |||
| Open | $7.64 | 52 Week Low | $ | |||
| Day High | $7.74 | P/E | N/A | |||
| Day Low | $7.50 | EPS | $ | |||
| Volume | 38,258 | |||||

